Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

NCT05269329 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Common Cold
Acute Respiratory Infection
Influenza, Human

Interventions

DRUG: XC8, film-coated tablets, 20 mg/day
DRUG: XC8, film-coated tablets, 40 mg/day
DRUG: XC8, film-coated tablets, 80 mg/day
DRUG: Placebo

Sponsor

Valenta Pharm JSC